SEC charges Keurig Dr Pepper for making inaccurate claims about K-Cups’ recyclability

SEC charges Keurig Dr Pepper for making inaccurate claims about K-Cups’ recyclability


Green tea pod is visible inside a Keurig brand coffee maker, Lafayette, California, December 17, 2022. Photo courtesy Sftm. 

Gado | Archive Photos | Getty Images

The Securities and Exchange Commission has charged Keurig Dr Pepper for making inaccurate claims about the recyclability of its disposable K-Cup pods, the agency said Tuesday.

Keurig has agreed to pay a $1.5 million civil penalty without admitting or denying the agency’s findings.

As consumers have become more conscious of their carbon footprints, questions about K-Cups’ environmental impact have dogged Keurig for more than a decade. The pods’ inventor told the Atlantic that he feels bad “sometimes” about creating K-Cups because of the waste they generate. A 2018 lawsuit over recycling claims led to a $10 million class-action settlement. By the end of 2020, K-Cups became fully recyclable, according to the company.

But before the company reached that milestone, it was already telling investors that the pods could be recycled.

Keurig said in its annual reports for fiscal 2019 and 2020 that testing with recycling facilities found that K-Cups could be effectively recycled. However, the SEC said that the company failed to disclose that two of the largest U.S. recyclers told Keurig that they didn’t intend to accept the disposable coffee pods for recycling and had expressed “significant concerns” about the financial viability of recycling K-Cups collected curbside.

The company’s claims could have swayed some consumers, boosting sales of both K-Cups and its brewers. Research conducted earlier by a Keurig subsidiary found that environmental concerns were a key factor that some shoppers considered when buying a Keurig coffee machine, according to the SEC.

In Keurig’s fiscal second quarter, sales of K-Cup pods and the company’s brewing systems accounted for nearly a quarter of the company’s revenue, according to a company filing.

In a statement, a company spokesperson said, “We are pleased to have reached an agreement that fully resolves this matter.”

“Our K-Cup pods are made from recyclable polypropylene plastic (also known as #5 plastic), which is widely accepted in curbside recycling systems across North America,” the spokesperson said. “We continue to encourage consumers to check with their local recycling program to verify acceptance of pods, as they are not recycled in many communities. We remain committed to a better, more standardized recycling system for all packaging materials through KDP actions, collaboration and smart policy solutions.”



Source

Pricey NFL, NBA ownership stakes are pushing investors to smaller leagues and driving valuations higher
Business

Pricey NFL, NBA ownership stakes are pushing investors to smaller leagues and driving valuations higher

Trinity Rodman #2 of Washington Spirit evades Sarah Schupansky #11 of Gotham FC during the NWSL Championship 2025 final between Washington Spirit and NJ/NY Gotham FC at PayPal Park on November 22, 2025 in San Jose, California. Lyndsay Radnedge/isi Photos | Isi Photos | Getty Images A version of this article first appeared in the […]

Read More
Hershey says GLP-1s are driving higher gum and mint sales
Business

Hershey says GLP-1s are driving higher gum and mint sales

Packages of Ice Breakers spearmint mints Mints are displayed at a Costco Wholesale store on April 27, 2025 in San Diego, California. Kevin Carter | Getty Images Hershey is seeing higher sales for its mints and gum — thanks to the growing use of GLP-1 drugs. “We’ve also seen strong demand for gum and mints, […]

Read More
More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says
Business

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly’s once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk’s Wegovy pill. Investors have been closely tracking […]

Read More